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Background
Pseudomonas aeruginosa has a high resistance to external
environmental conditions, with a remarkable ability to
adapt and numerous virulence factors, being involved in
the etiology of nosocomial infections and severe infections
in immunodeficient patients. The strains isolated in hospi-
tals need supervision due to the risk of transmission and
antibiotic resistance.
We pursued the epidemiological context to elaborate
therapeutic recommendations on first-line antibioterapy
adapted to the evolution of antibiotic resistance of Pseudo-
monas strains isolated from pathological products col-
lected from hospitalized patients in non-ICU departments
of the hospital.
Methods
The retrospective study included 192 patients diagnosed
with infections caused by P aeruginosa hospitalized in the
“Victor Babeş” Hospital Craiova in the period 01 January
2006 – 31 December 2012. We evaluated the studied cases
based on the following parameters: the risk of infection with
antibiotic-resistant germs (Carmeli score), infection localiza-
tion and antibiotic resistance profile of the isolated strains
of P aeruginosa, achieved by the classical diffusimetric
system.
Results
The annual evolution of cases showed an upward trend
since 2009, the age groups most affected were infants
(8.3% of cases), small children (11.1%) and the elderly
over 65 years (26.5%). According to the Carmeli score,
patients were divided into 3 categories: 4 patients (2.1%)
with community infections, 112 patients (58.4%) with
community apparent infections and 76 patients (39.5%)
with probable nosocomial infections. The location of
infection was: respiratory (49.6%), ear (16.1%), urinary
(12.8%), digestive (10.1%), overinfected wounds (2.7%),
sepsis (1.6%), other sites (ocular, articular) 1%.
Antibiotic sensitivity was: colistin 99.1%, quinolone
88.7%, cefoperazone-sulbactam 88%, aminoglycosides
87.7%, meropenem 84.4%, aztreonam 83.9%, piperacillin-
tazobactam 82.14% ticarcillin-clavulanate 77.3%, ceftazi-
dime 73.8%, cefpirome 72.7%, ceftriaxone 71.6%, cefepime
60.9%, amoxicillin-clavulanate 16.1%. The comparative
analysis of antibiotic sensitivity according to the Carmeli
score indicates caution in the use of cephalosporins and
quinolones for patients with Carmeli score 3, since these
patients probably have infections with antibiotic resistant
strains. The risk for strains of P aeruginosa to be carbape-
nem-resistant showed respiratory and urinary localization
and wound infections. Colistin was the safest alternative
treatment for P aeruginosa strains resistant to meropenem,
becoming the most effective antibiotic in the absence of its
use for a long time.
Conclusion
The antibiotic resistance of P aeruginosa was determined
by antibiotic selection pressure, the chemosensitivity data
are useful in developing therapeutic recommendations
tailored to the local situation.* Correspondence: dan_hurezeanu@yahoo.com1University of Medicine and Pharmacy Craiova, Romania
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